As mentioned above, survivin expression was previously reported to significantly correlate with poor prognosis in a range of malignant tumors, such as colorectal cancer [12], bladder cancers [33], lymphoma[10], soft-tissue sarcomas[11]. Here, BIRC5 is linked to lymphoma.